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Abstract—Toxicity of dioxins is wide ranging. Amongst the organs, the liver is the most susceptible to damage
by dioxins. Damage caused to liver cells results in promoting inflammatory processes. The aim of this workwas
to evaluate whether high doses of tocopherol will change the inflammatory response, monitored by biochemical
indicators, by improving liver function in rats exposed to tetrachlorodibenzo-p-dioxin (TCDD). The study was
conducted on a population of female Buffalo rats. The animals were divided into the following groups: Control
Group A—representing physiological norms for the studied diagnostic indicators; Control Group B—subjects
were administered a 1%ceragenin solution to induce pleuritis; StudyGroup 1—where ratswere administeredα-
tocopherol acetate for 3 weeks, after which pleuritis was induced; Study Group 2—rats were administered a
single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), while 3 weeks later, pleuritis was induced; and
Study Group 3—rats were administered a single dose of TCDD and next, were administered α-tocopherol
acetate for 3weeks, followed by pleuritis induction. The results clearly show that administering tocopherol in the
course of inflammation causes changes to the distribution and ratio of in the serum protein fractions, including
acute phase proteins. The latter proteins are indicative to the improvement in liver function and linked to protein
synthesis and stimulation of the antibody-mediated immunity. Moreover, in the course of inflammation caused
by exposure of rats to TCDD, tocopherol significantly affected the acute phase protein concentration.
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INTRODUCTION
The liver plays an important role in the synthesis of
proteins involved in inflammatory reactions. The protein
metabolism in hepatocytes is significantly affected by
dioxins that are slowly and gradually accumulating in the
body, mainly in adipose tissue and the liver. This accumu-
lation leads to disruption in the synthesis of plasma pro-
teins, i.e. albumin, α1, α2, β1, β2 and γ globulin fractions
and fibrinogen. Between 25 and 75% of the daily dioxin
dose is deposited in the liver [1]. Administering 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) results in changes in
the endoplasmic reticulum of the hepatocytes and increases
coproporphyrin concentration [2]. The latter in turn affects
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the synthesis of acute phase proteins, whose concentration
increases rapidly during inflammation [3]. When rats are
injected with dioxins, protein synthesis taking place in liver
cells is disrupted on the genomic level. Pro-inflammatory
interleukins, such as Il-1, Il-6 and TNF (tumour necrosis
factor), act as regulators in the synthesis of plasma proteins
[4–6] while increase in alanine aminotransferase activity in
rats treated with TCDD is a sign of liver damage [7]. Our
studies show that when rats were administered 5-μg/kg
body weight of TCDD for a period of 5 weeks, they
displayed significant macroscopic changes in the liver
and microscopic histopathological changes in the hepato-
cytes. The changes manifested themselves in steatosis, and
laboratory tests showed increased cholesterol concentra-
tion in plasma as well as disorders in oestrogen metabolism
[8, 9]. Dioxins significantly affect the structures of the
connective tissue, disrupting its linearity, promoting de-
structive processes and disturbing spatial distribution dur-
ing regeneration processes [10]. As a result, the disrupted
collagen architecture in a parenchymatous organ, such as
the liver, causes destructive changes in its vascularisation.
Moreover, oxidative stress was shown to significantly af-
fect the expression of the hepatic gene responsible for the
synthesis of collagen [11].
Due to dioxins’ strong pro-inflammatory character-
istics, such as generation of free radicals and induction of
COX-2 (cyclooxygenase-2) [12], we have attempted to
eliminate the pro-inflammatory multidirectional effect of
dioxins by using tocopherol’s acetate derivative. The
results of our previous studies showed that administering
large doses of tocopherol improves many biochemical
blood indicators [13, 14]. Free radicals are generated as a
result of dioxin metabolism with CYP1A1 enzymes. This
process leads to formation of the reactive oxygen species
(ROS) in many organs [12, 15–22]. Tocopherol deficit in
cases of inflammation causes significant oxidative stress,
which leads to fibrogenesis [11, 23, 24]. Vitamin E is a
compound with strong antioxidative properties, which pro-
tects tissues from negative effects of the ROS [15, 25, 26].
Moreover, studies by Kloser et al. [27] show the antago-
nistic effect of tocopherol on the aryl hydrocarbon receptor
(AhR). It means that the compound is helping in elimina-
tion of free radicals generated as a result of TCDD metab-
olism by blocking the Ah receptor and subsequently dis-
rupting of cytochrome P450, family 1, subfamily A, poly-
peptide (CYP1A1) synthesis, thus preventing the genera-
tion of free radicals. This sequence of the events also
provides an explanation for the layout of our study where
we demonstrate beneficial changes in the biochemical
parameters in rats injected with TCDD and subsequently
receiving large doses of tocopherol for 3 weeks [13, 25,
28]. Lauritzen et al. [29] showed that during bacterial
pneumonia, concentrations of the tocopherol and ascor-
bic acid in plasma were decreased, which led in turn to
increased permeability of lysosomal membranes. The
results of a study by Norazlin et al. [30] showed that
administering tocopherol slowed the secretion of pro-
inflammatory cytokines, Il-1 and Il-6, into plasma in
animals exposed to nicotine. Our own studies showed
similar effects in animals under the effects of TCDD,
which received large doses of tocopherol for 3 weeks
and in which we observed significant decreases in pro-
inflammatory interleukins, especially TNF [13]. Stud-
ies by Devaraj et al. [31] confirmed that prolonged use
of tocopherol limits the release of peroxide anions and
hydrogen peroxide, decreasing Il-1 concentrations.
Studies by Tsukamoto et al. [32] showed that admin-
istering tocopherol inhibits the expression of mRNA,
Il-6 and TNF.
This work is a continuation of previous studies.
Here, we decided to assess the level of acute phase
plasma proteins, such as haptoglobin and transferrin,
while demonstrating the preventative role of tocopherol
on liver damage. It is important to note that these
proteins participate in securing iron release from
broken-down erythrocytes during inflammation modu-
lated by dioxins. We have undertaken to analyse the
effect of a 3-week tocopherol regimen, assuming a
dose of 30-mg/kg body weight, on plasma protein
and selected biochemical parameters in rats which
were under the effects of TCDD and in which we
induced inflammation.
MATERIAL AND METHODS
Female Buffalo rats, weighing between 130 and
150 g, aged between 9 and 11 weeks, were inbred and
provided by the Department of Pathologic Anatomy of
Wroclaw Medical University. The air-conditioned rooms
where the animals were held were equipped with hyper-
tension, the air was exchanged 15 times per hour, the
temperature was kept at 22 °C, humidity at 55%, and the
daylight cycle was 12/12 h. The rats were kept in polysty-
rene cages, each holding six specimens, with free access to
water and food (BMurigran^).
For the purposes of the study, the animals were divid-
ed into the following groups:
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Y Control Group A—representing physiological norms for
the studied diagnostic indicators;
Y Control Group B—rats with pleuritis, induced by ad-
ministering 1% ceragenin solution, volume 0.15 ml,
injected into the pleural cavity at 5/6 right intercostal
space;
Y Study Group 1—rats were administered α-tocopherol
acetate for 3 weeks, dose 30-mg/kg body weight/day,
and subsequently, pleuritis was induced following the
same procedure as in the Control Group B;
Y Study Group 2—rats were administered a single dose of
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) diluted in
dimethyl sulfoxide (DMSO), dose 5-μg/kg body weight,
3 weeks before pleuritis was induced with ceragenin;
Y Study Group 3—rats were administered a single dose of
TCDD, dose 5-μg/kg body weight, 3 weeks before
pleuritis was induced with ceragenin; after being admin-
istered TCDD, the animals were administered α-
tocopherol acetate for 3 weeks, dose 30-mg/kg body
weight/day.
The study material constituted blood drawn from
the abdominal aorta of the rats, which were anaesthe-
tized with barbiturates, i.e., 30 mg/kg body weight of
sodium pentobarbital. After desanguination animals
were decapitated and rats’ carcases were incinerated.
The following chemical and pharmacological agents
and diagnostic tests were used in the study: model TCDD
solution, diluted in DMSO, concentration 1 μg/ml, ac-
quired at the Laboratory for Trace Analysis, Institute of
Chemistry and Inorganic Technology, Kraków Polytech-
nic; ceragenin (Sigma); α-tocopherol acetate (Hasco-Lek);
and sodium pentobarbital (Biochemie GmbH).
Study Methods
The following biochemical tests were performed on
rats’ serum and plasma:
Electrophoresis—the sera were separated in buffered
agarose gel at 100-Velectrical field for a period of 35 min,
using a Sebia–Hydrasys system, (Horiba ABX). The gel
scanning was performed with a Sebia–Hydrasys densitom-
eter at 600 nm, and protein fraction concentration was
given in g/dl;
The concentration (mg/dl) of the acute phase protein
markers, i.e. complements C3 and C4, haptoglobin, trans-
ferrin, as well as IgG and IgM, was determined by immu-
nonefelometry with a Dade Behring nefelometer, using
diagnostic sets provided by the manufacturer.
Statistical Analysis
The results were subjected to statistical analysis. We
calculated the total number (n), arithmetical means (mean),
standard deviations (SD) and ranges for minimal (min) and
maximal (max) values.
Having verified whether the calculated parameters
have normal distribution (by comparing the variables’
histogram with a Gauss curve diagram), the means for
particular indicators for the A and B Control Groups and
for the Control Group B and Study Groups, in which
tocopherol and TCDD were administered, were compared
using Student’s t test with statistical significance set at the
following: *p ≤ 0.05, **0.05 > p ≥ 0.01, and ***p ≤ 0.001.
Calculations were performed using Statistica 7.01.
RESULTS
Serum Protein Analysis (Table 1)
Albumins In the Control Group B, blood samples
withdrawn at 24 and 72 h since induction of the inflamma-
tion showed a significant decrease in absolute and relative
albumin concentration. In the Study Group 1 with induced
inflammation and administered tocopherol, we observed a
significant increase in absolute and relative albumin con-
centration for the same time period, in comparison with the
results from the Control Group B. In the Study Group 2
with induced inflammation and treated with dioxin, we
observed a significant decrease in albumin concentration
in comparison with that in the Control Group B. In a
similar group with induced inflammation and treated with
both dioxin and vitamin E, we observed an increase in the
absolute and relative albumin concentration in comparison
with that in the group that did not receive tocopherol
(Fig. 1).
Globulin α1. In the Control Group B, with induced
inflammation, the measurements were performed in three
time periods and showed a significant increase in the
absolute and relative concentration of this protein fraction
in comparison with that in the group that had no induced
inflammation. Administering tocopherol in the Study
Group 1 with induced inflammation resulted in a decrease
of both absolute and relative concentration of globulin α1,
in comparison with that in the Control Group with induced
inflammation. In the Study Group 2 with induced inflam-
mation and treated with dioxin, we observed a significant
increase in the concentration of this globulin fraction in the
120th hour sample in comparison with that in the Control
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Group B. The administration of tocopherol in a similar
group that received dioxin resulted in a significant decrease
in the concentration of this protein fraction in comparison
with that in the group where rats were treated with dioxin
that had not received tocopherol (Fig. 1).
Globulin α2. In the Control Group B, with induced
inflammation, the measurements performed in three time
periods showed a significant increase in the absolute and
relative concentration of this protein fraction. In the Study
Group that apart from induced inflammation received to-
copherol, after 120 h, we observed a significant decrease in
the concentration of this globulin fraction in comparison
with that in the Control Group B. In the Study Group with
induced inflammation and treated with dioxin, we have
also observed a significant decrease in the concentration
of this globulin fraction after 120 h (in comparison with
that in the Control Group B). However, in the group treated
with both dioxin and tocopherol, we observed a decrease in
the concentration of the globulin α2 after 72 and 120 h
since induction of the inflammation (Fig. 1).
Globulin β. In the Control Group B, with induced
inflammation, we did not document any significant differ-
ences for this protein fraction in comparison with the
results obtained for the Control Group A, without induced
inflammation. The administration of tocopherol in the
Study Group 1 with induced inflammation did not result
in statistically significant changes, as compared to that in
the previous group. After 72 and 120 h in the Study Group
2 with induced inflammation and treated with dioxin, we
observed an increase in the absolute and relative concen-
tration of the globulin β, while in the group treated with
both dioxin and tocopherol, there was a significant de-
crease in the absolute concentration of this globulin frac-
tion (Fig. 1).
Globulin γ. In the Control Group B, we observed a
slight decrease of the γ globulin fraction in comparison
with that in the Control Group A, without induced inflam-
mation. In the Study Group 1 rats with induced inflamma-
tion and injected with tocopherol, after 120 h, we observed
a significant increase in the concentration of this protein in
comparison to that in corresponding sample for the Control
Group B. However, γ globulin concentration after 24 h
was significantly increased in the Study Group 2 in com-
parison with that in the animals from the Control Group B.
The administration of tocopherol in the Study Group 3 with
induced inflammation and treated with dioxin resulted in a
significant increase of the γ globulin fraction after 24 and
72 h, in comparison with that in the group treated with






































































































































































































































The Influence of α-Tocopherol on Serum Biochemical Markers
Total Serum Protein. In the Control Group B, with
induced inflammation, the assays performed for samples
taken at three time periods showed no differences in com-
parison with results obtained for the Control Group A. In
the Study Group 1 after 24 h, we observed a slight increase
in total serum proteins, with a tendency to remain at a
constant level. In the Study Group 2, we did not observe
any significant differences in the concentration of the total
serum proteins after 24 and 72 h in comparison with that in
the Control Group B. The total serum proteins increased in
the Study Group 3 with induced inflammation and where
rats were injected with both dioxin and tocopherol in
comparison with those in the Study Group 2 (Fig. 1).
Serum Albumin to Globulin Ratio. Serum albumin/
globulin ratio (RSA/RSG) was determined for the Control
Group B (with induced inflammation) and compared to that
of the Control Group A (without induced inflammation).
The administration of tocopherol to rats with induced in-
flammation caused a slight increase of RSA/RSG in com-
parisonwith that in the Control GroupB. In the StudyGroup
with induced inflammation and treated with dioxin, RSA/
RSG was slightly lower than that in the Control Group B.
The injection of tocopherol to rats with induced inflamma-
tion and treated with dioxin after 24 and 72 h caused a
significant increase of this indicator in comparison with rats
that have not received tocopherol (Fig. 2).
Analysis of Biochemical Indicators (Table 2)
Immunoglobulin M. In the Control Group B, with in-
duced inflammation, after 24 h, we observed a decrease of
the immunoglobulinM (IgM) concentration, while after 72
and 120 h, we observed a significant increase in concen-
tration of this immunoglobulin. The administration of to-
copherol to rats with induced inflammation caused an
increase of the IgM, while a significant decrease of this




















































































































hour of inflammation [h]
a b
c d
Fig. 1. Electrophoretic separation of rat sera: aControl Group B; induced pleuritis; b Study Group 1; induced pleuritis and administration of α-tocopherol; c
Study Group 2; induced pleuritis after administration of dioxin; d Study Group 3; induced pleuritis after administration of dioxins and injection of α-
tocopherol.
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administration of tocopherol in the group with induced
inflammation and treated with dioxin caused an increase
in the concentration of the IgM after 24 and 72 h from
induction of the inflammation, in comparison to that in the
rats that have not received tocopherol (Fig. 3).
Immunoglobulin G. After 24 and 72 h, the rats in the
Control Group B and Control Group A showed no signif-
icant changes in the concentration of this immunoglobulin.
On the other hand, administration of tocopherol to the
group of rats with induced inflammation caused a signifi-
cant decrease in immunoglobulin G (IgG) concentration.
When rats with induced inflammation were treated with
dioxin, a significant decrease of the IgG concentration in
serum was observed. Injection of both tocopherol and
dioxin to rats with induced inflammation caused an in-
crease in the concentration of this immunoglobulin in
comparison to that in the rats that were not injected with
tocopherol (Fig. 3).
Complement Component 3. In the Control Group B,
with induced inflammation, we observed 30-fold increase
in the concentration of this protein, with the maximum
value documented after 24 h from induction of the inflam-
mation. In the group with induced inflammation and trea-
ted with dioxin, we observed an increase in concentration
of this protein, which remained at that level throughout the
experiment points. The administration of tocopherol in the
group with induced inflammation and treated with dioxin
did not cause any significant change in complement com-
ponent 3 (C3) concentration (Fig. 4).
Complement Component 4. In the rats with induced
inflammation (Control Group B), the concentration of
component 4 (C4) decreased by 50% after 24 and 72 h,
in comparison to that in the rats that were not subjected to
induced inflammation (Control Group A). When rats with
induced inflammation received tocopherol, after 120 h,
there was fourfold increase in the concentration of this
indicator (Fig. 4). In the group with induced inflammation
and treated with dioxin, we also observed a significant
increase in the C4 concentration. The administration of
tocopherol to rats with induced inflammation and treated
with dioxin did not significantly change the concentration
of the C4 in all three time points (Fig. 4).
Transferrin. In the Control Group B, with induced
inflammation, after 24 and 72 h, we observed a slight
increase in transferrin (TRF) concentration, while after
120 h of inflammation, there was a significant decrease in
the concentration of this indicator. The administration of
tocopherol to rats with induced inflammation brought
transferrin concentration at 120-h samples to the same level
as observed after 24 and 72 h. In the group with induced
inflammation and treated with dioxin, we observed a sig-
nificant increase in transferrin concentration in all three
time points. The administration of the tocopherol to rats
with induced inflammation and treated with dioxin caused
a noticeable decrease in this indicator to a level similar to
that observed for rats that had induced inflammation and
were injected with tocopherol (Fig. 5).
Haptoglobin. In the Control Group B, with induced
inflammation, concentration of haptoglobin increased 16-
fold. Administration of tocopherol to rats with induced
inflammation did not cause significant changes to this
indicator. In the group with induced inflammation and
treated with dioxin, we observed an increase in the con-





















hour of inflammation [h]
pleuritis + vit. E pleuritis pleuritis + TCDD + vit. E pleuritis + TCDD
Fig. 2. Albumin to globulin (RSA/RSG) ratio in different study groups.
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Table 2. The Changes of Biochemical Inflammatory Indices With and Without Exposure to Dioxin














Control 0 n 7 7 7 7 7 7
Mean 306.57 38.80 1.51 9.42 112.60 4.41
SD 33.65 5.12 1.10 1.94 8.23 1.54
Pleuritis 24 n 7 7 7 7 7 7
Mean 331.00 26.87 53.16 4.09 142.91 72.53
SD 33.82 5.23 11.53 0.97 23.31 15.38
p NS ** *** *** ** ***
72 n 7 7 7 7 7 7
Mean 273.86 65.81 43.47 5.23 136.47 81.16
SD 40.60 13.26 2.36 2.11 11.30 4.32
p NS *** *** ** *** ***
120 n 7 7 7 7 7 7
Mean 568.57 61.50 35.39 10.18 32.26 61.69
SD 34.98 6.16 2.79 1.29 3.46 5.19
p NS *** *** NS *** ***
Pleuritis + vit. E 24 n 7 7 7 7 7 7
Mean 200.43 30.86 52.44 14.68 151.94 70.74
SD 23.92 6.28 2.81 6.62 51.57 6.09
p *** NS NS *** NS NS
72 n 7 7 7 7 7 7
Mean 181.57 82.71 54.77 14.03 142.73 74.54
SD 15.54 9.64 4.46 2.12 27.15 5.27
p *** * * *** NS NS
120 n 7 7 7 7 7 7
Mean 232.00 71.57 52.63 37.29 194.33 64.10
SD 18.69 7.41 3.27 17.29 47.90 16.85
p *** * *** ** *** NS
Pleuritis + TCDD 24 n 6 6 7 7 7 7
Mean 168.33 19.07 50.06 13.18 189.97 79.50
SD 26.00 3.70 1.70 2.71 44.67 9.72
p *** * NS *** ** NS
72 n 6 6 7 7 7 7
Mean 180.17 38.50 55.80 25.08 188.77 89.09
SD 10.34 8.34 2.69 1.32 29.72 21.16
p *** ** * *** *** NS
120 n 6 6 7 7 7 7
Mean 84.00 50.27 51.43 34.27 230.04 157.80
SD 12.85 4.79 3.36 5.26 11.30 17.48
p *** ** *** *** *** ***
Pleuritis + TCDD + vit.
E
24 n 6 6 7 7 7 7
Mean 203.00 36.43 49.97 15.96 228.87 100.23
SD 40.98 6.63 4.60 3.75 45.06 12.27
p NS *** NS NS NS **
72 n 6 6 7 7 7 7
Mean 194.67 48.97 54.51 19.66 150.96 176.14
SD 8.64 5.96 4.87 9.97 22.05 15.47
p * * NS NS * ***
120 n 6 6 7 7 7 7
Mean 209.00 53.15 51.70 24.17 151.11 166.79
SD 26.97 11.91 3.74 8.14 17.64 30.01
p *** NS NS NS *** NS
IgG immunoglobulin G, IgM immunoglobulin M, C3 complement component 3, C4 complement component 4, TRF transferrin, Hapt haptoglobin, n total
number, SD standard deviations
p statistical significance: NS not significant; *p ≤ 0.05; **0.05 > p ≥ 0.01; ***p ≤ 0.001
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in the Control Group B. The administration of tocopherol
to dioxin-treated rats caused an increase in Hapt, especially
after 72 h (Fig. 5).
DISCUSSION
The transferrin and albumin tested in this study
are the elements of the acute phase protein group
which react negatively [33–36]. The results from the
group of rats subjected to induced inflammation and to
tocopherol showed a lower decrease in albumin con-
centration after 24 and 72 h than one reported in our
previous study [28]. The group of rats with induced
inflammation and treated with both TCDD and tocoph-
erol showed a smaller decrease of the albumin concen-
tration in comparison with the analogous group that did
not receive tocopherol.
The electrophoretic analysis of proteins in serum of
the animals with induced inflammation and treated with
tocopherol showed a decrease of α1 and α2 globulin frac-
tions after 72 and 120 h, while these proteins were increas-
ing in the control rats with pleuritis. On the other hand, the
concentrations of γ globulin, total protein and albumin to
globulin ratio (RSA/RSG) in tocopherol-treated rats dis-
played a tendency to increase in comparison with those in
the animals that did not receive tocopherol. In overall,
results suggest that administration of tocopherol to both
groups of rats, with induced inflammation and treated with
































































Fig. 3. Influence of α-tocopherol on immunoglobulin M (IgM) and immunoglobulin G (IgG) concentration in serum of rats with pleuritis, with and without
exposure to dioxin.
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led to a decrease in concentrations ofα1,α2 andβ globulin
fractions, as well as an increase of γ globulin, total protein
and the RSA/RSG. The dynamics of the changes in differ-
ent protein fraction concentrations are also time-dependent,
as what can be seen by the example of the α1 globulin
fraction reaching maximum concentration after 72 h since
the induction of inflammation, i.e. at the same time as the
other proteins such as albumin, γ globulin and the albumin
to globulin ratio. Moreover, in this time period, we ob-
served the maximum increase in leucocyte count in periph-
eral blood, together with a decrease in neutrophils and fall
in both erythrocyte count and haematocrit, the latter being
linked to albumin to globulin ratio [25, 37]. Vos et al. [38]
showed that dioxins cause an increase in α and β glob-
ulins, and this observation is supported by results presented
in this study. The aforementioned study used a similar
experimental model, but not as extensive as the one pre-
sented in this study. Here, we analysed the changes in
composition of the serum proteins in rats with induced
inflammation and subjected to the TCDD treatment. In
animals that received tocopherol, acute phase proteins’
concentration changed between the 72nd and 120th hour
of inflammation. The results did not show similar time
period-related interdependencies regarding biochemical
parameters, as in the case of the previously described
control group with induced inflammation, where, depend-
ing on the indicator, the peak of changes occurred between
the 72nd and 96th hour of inflammation [28]. In a light of
these observations, we hypothesize that rats in the groups
that received tocopherol, the monitored indicators do not
reach their potential maximal values, but rather remained at




























































Fig. 4. Influence of α-tocopherol on changes in the concentrations of complement C3 and C4 in serum of rats with pleuritis, with and without exposure to
dioxin.
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obtained for other biochemical parameters monitored when
using a similar experimental model [13].
The observed increase in IgM concentration at three
experimental time periods (24, 72 and 120 h) in the control
group with induced inflammation also occurred in the
study group that received tocopherol, as what can be con-
strued as the effect of this vitamin on the synthesis of the
abovementioned immunoglobulin. We have also shown a
decrease in IgG concentration in the study group with
induced inflammation and administered tocopherol.
The immunosuppressive effect of dioxins [39, 40] has
also been confirmed in this study through the analysis of
IgG and IgM in the study group of rats with induced
inflammation and treated with TCDD. In this case, IgG
concentration decreased sixfold and IgM concentration
twofold in comparison with those in the control group with
induced inflammation. Suppression in the production of
several classes of immunoglobulins, i.e. IgG, IgE and IgM
in B lymphocyte cultures, was shown by Karras et al. [41].
When one study group received tocopherol for
3 weeks, from the moment when dioxin was administered
and until the inflammation was induced, we observed an
increase in IgG and IgM in comparison with those in the
control group that had not been treated with tocopherol.
This shows that synthesis of these two immunoglobulins
can improve after administering tocopherol. As inflamma-
tion promotes the oxidative stress [29], it causes a release
of large amounts of free radicals [42–45]. The oxidative
stress is strengthened after administration of dioxins.
In spite of the fact that transferrin is recognized as one
of the acute phase proteins, which are known to decrease





























































Fig. 5. Concentration of transferrin (TRF) and haptoglobin (Hapt) in serum of rats with induced inflammation and exposed, or not to dioxin.
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concentration remained unchanged in the early stages of
the inflammation. Only after 72 h into the experiment,
there was a significant decrease in transferrin concentra-
tion. In the studies conducted on monkeys that received
small doses of TCDD, Riecke et al. [46] demonstrated an
increase in transferrin concentration in the liver. The anal-
ysis of our results indicates that administration of the
tocopherol to rats with induced inflammation results in a
reverse type of response, manifested by a considerable
increase in TRF concentration. We have also observed that
rats with inflammation exposed to dioxins had significantly
increased transferrin concentration. The administration of
tocopherol in a group of rats treated earlier with dioxin
decreased the TRF concentration in comparison to that in
the animals that have not received the vitamin E. Transfer-
rin is known for its role in capturing iron from heme,
released from broken-down erythrocytes, and transporting
it to the endothelial reticulum. This process is probably
associated with the significant decrease in the erythrocyte
and haemoglobin count in later stages of inflammation
[47]. Pro-inflammatory factors, such as IL-1, IL-6 and
TNF, stimulate hepatocytes to synthesize acute phase pro-
teins, haptoglobin and transferrin, which participate in
preventing iron complexes and its free form from becom-
ing available to bacteria [48, 49]. Notably, in rats treated
with dioxin, during inflammation, transferrin concentration
increased while the erythrocyte and haemoglobin count
decreased.
The analysis of serum haptoglobin concentration
in the group of rats with induced inflammation and
treated with tocopherol showed no significant differ-
ences in comparison with that in a similar group
which have not received the vitamin E. In the group
of animals exposed to dioxin, a significant increase in
haptoglobin concentration, together with an increase
in transferrin concentration, was found in the 120-
h sample. Administering tocopherol in the group with
induced inflammation and treated with dioxin was
associated with a significant increase in haptoglobin
concentration, the phenomenon that can be attributed
to the improvement in the synthesis of this protein.
However, production of the haptoglobin might be
stimulated by decrease in serum pro-inflammatory
interleukins IL-1β, IL-6 and TNF, that is caused by
administration of tocopherol, as described by Ahmad
et al. [23], Jialal et al. [50], Norazlin et al. [30] and
Wang et al. [51].
Analysis of complement C3 and C4 concentrations
shows that significant differences between C3 and C4
levels appear only in the control group with induced
inflammation. In the initial stage of the inflammation,
complement C4 concentration has significantly decreased,
whereas complement C3 concentration has increased, even
though C3 is characterized as a low-response protein
according to Koj’s classification [36]. Tocopherol admin-
istered to the group with induced inflammation exerts its
effect by causing an increase in both complement C3 and
C4 concentrations. The complement C3 and C4 concen-
trations have increased in serum of rats with induced
inflammation and treated with TCDD. When rats with
induced inflammation and treated with dioxin received
tocopherol, there was no significant change in the concen-
tration of these proteins. The elevated complement C3 and
C4 concentrations in rats with inflammation and treated
with dioxin may cause a significant decrease of the eryth-
rocyte count, due to haemolytic properties of these pro-
teins, or also due to morphological disorders in erythrocyte
membranes occurring as a result of increased oxidative
stress caused by the effects of TCDD [47].
CONCLUSIONS
In cases of inflammation, tocopherol contributes to
significant changes in serum and plasma protein concen-
trations. By using electrophoretic separation of the serum
proteins, we have ascertained that tocopherol stimulates an
increase in albumin and γ globulin concentration as well as
the albumin to globulin ratio, whereas it prevents the
increase of α1 and α2 globulin concentrations. Moreover,
the increase of complement C4 concentration intensifies,
while the period over which increased transferrin and com-
plement C3 concentrations are being maintained has sig-
nificantly lengthened without any significant effect on
haptoglobin concentration. In cases of inflammation, to-
copherol intensifies the increase of immunoglobulin M
concentration and lowers immunoglobulin G concentra-
tion. The presented results clearly show that in case of
inflammation, administration of tocopherol leads to
changes in the serum protein fractions, including acute
phase proteins, as what argues in favour of improved liver
function associated with protein synthesis and stimulation
of the antibody-mediated immunity.
Tocopherol significantly affects acute phase protein
concentration in inflammation after administration of
TCDD by limiting the dioxin-induced increase in transfer-
rin concentration in advanced stages of this process. How-
ever, it causes a significant increase in concentrations of
haptoglobin, and it does not accelerate the appearance of
complement C3 and C4 proteins. This proves that the effect
Całkosiński, Gostomska-Pampuch, Majda, Leśków, Janeczek, Melnyk, and Gamian
of TCDD on some processes involved in inflammatory
response is so long-lasting that even extended use of to-
copherol cannot affect the course of these processes.
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